Analysts who follow AbCellera Biologics Inc (ABCL) on average expect it to increase 71.09% over the next twelve months. Those same analysts give the stock an average rating of Hold.
That average rating earns AbCellera Biologics Inc an Analyst Ranking of 77, which means it ranks higher than 77 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With AbCellera Biologics Inc Stock Today?
AbCellera Biologics Inc (ABCL) stock is trading at $29.37 as of 9:34 AM on Thursday, Apr 15, a rise of $1.12, or 3.96% from the previous closing price of $28.25. The stock has traded between $29.25 and $29.74 so far today. Volume today is light. So far 34,754 shares have traded compared to average volume of 1,407,860 shares.
Click Here to get the full report on AbCellera Biologics Inc (ABCL) Stock.
